(RTTNews) - BavarianNordic (BVNKF.PK) has submitted clinical ... The company said, following review of the data by EMA, the Marketing Authorisation for IMVANEX could be extended to include ...
Following review of the data by EMA, the Marketing Authorisation for IMVANEX could be extended to include use of the vaccine for adolescents during the fourth quarter of 2024. BavarianNordic is ...
BavarianNordic A/S has submitted clinical data to the European Medicines Agency (EMA) to support the extension of the Imvanex (MVA-BN) smallpox and mpox vaccine indication to include ...
Paul Chaplin, President & CEO of BavarianNordic, said: "We applaud EMA for their expedited review and decision to recommend approval of MVA-BN for adolescents. This represents an important ...
COPENHAGEN, Denmark, August 16, 2024 – BavarianNordic A/S (OMX: BAVA) has submitted clinical data to the European Medicines Agency (EMA) to support the extension of the IMVANEX ® (MVA-BN ®) ...
Results that may be inaccessible to you are currently showing.